Form 4: Hims & Hers CFO Oluyemi Okupe Executes Pre-Planned Stock Option Exercise and Sale

Hims & Hers Health, Inc.'s Chief Financial Officer, Oluyemi Okupe, executed a pre-planned transaction on July 14, 2025, involving the exercise of stock options and the subsequent sale of Class A Common Stock.

Summary

• Oluyemi Okupe, Chief Financial Officer of Hims & Hers Health, Inc. (HIMS), engaged in a pre-planned transaction on July 14, 2025, under a Rule 10b5-1 trading plan adopted on May 31, 2024.
• Exercised stock options to acquire 7,587 shares of Class A Common Stock at an exercise price of $5.01 per share.
• Sold 11,581 shares of Class A Common Stock at an average weighted price of $47.7004 per share, with prices ranging from $47.46 to $47.995.
• Following these transactions, Oluyemi Okupe directly holds 54,084 shares of Class A Common Stock and 372,946 stock options.
• An additional 70,575 shares of Class A Common Stock are indirectly held by the Oluyemi Okupe Separate Property Trust dtd 9-1-2021.

Sentiment

Score: 5

Explanation: Neutral. The Form 4 reports a routine, pre-planned insider transaction (option exercise and sale) by the CFO. While it involves a sale of shares, the existence of a Rule 10b5-1 plan mitigates any negative sentiment typically associated with insider selling, as it indicates a non-discretionary, scheduled event.

Positives

• Transactions were executed under a pre-arranged Rule 10b5-1 trading plan, indicating a pre-scheduled, non-discretionary sale rather than a reaction to immediate company news.
• The sale price of $47.7004 per share is significantly higher than the exercise price of $5.01, indicating a substantial gain for the CFO on the exercised options.

Negatives

• The sale of 11,581 shares by a key executive, even if pre-planned, represents a reduction in direct beneficial ownership of Class A Common Stock.

Future Outlook

N/A

Industry Context

This Form 4 details a routine insider transaction (option exercise and sale) by a CFO. Such transactions are common across industries, especially when executives' equity compensation vests and they utilize pre-planned trading programs like Rule 10b5-1 plans for liquidity or diversification. It does not provide specific industry trends.

Stakeholder Impact

• Shareholders: The sale of shares by a CFO could be perceived negatively by some, but the Rule 10b5-1 plan context suggests it's a routine liquidity event rather than a signal of lack of confidence. The high sale price relative to exercise price indicates the executive is realizing significant gains from their equity compensation.

Next Steps

• Continued vesting of remaining stock options according to the established schedule.

Key Dates

Recommendation

Keywords

Hims & Hers Health, HIMS, SEC Form 4, Insider Trading, Stock Option Exercise, Stock Sale, Oluyemi Okupe, Chief Financial Officer, Rule 10b5-1 Plan, Equity Transaction